Evidence map›Paper›PMID 41588478›Full record

SynthesisStem cell research & therapy2026

Stem cell therapies for pulmonary fibrosis: emerging hope through ongoing challenges.

Hanyu Shi, Ruihui Geng, Hui Liu

Abstract readSystematic Review
In one paragraph

Synthesis in Stem cell research & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hanyu ShiDepartment of Internal Medicine, Hospital of the First Mobile Corps of the Chinese People's Armed Police Force, Dingzhou, 073099, Hebei, China.
Ruihui GengDepartment of Internal Medicine, Hospital of the First Mobile Corps of the Chinese People's Armed Police Force, Dingzhou, 073099, Hebei, China.
Hui LiuDepartment of Weigongqiao Outpatient, Jingxi Medical Section of PLA General Hospital, 1#, West Third Ring Road, Beijing, 100089, China. lh00912@126.com.

Funding

Independently Developed Research Project of the Chinese Armed Police ZZKY20243122
6 · The paper itself

Abstract

Stem cell therapy represents an emerging intervention for pulmonary fibrosis (PF), a severe lung disease lacking effective treatments. We conducted a systematic retrospective review of stem cell clinical trials for PF registered up to the end of 2024, utilizing the Trialtrove database alongside other registries.

Indexed as

Pulmonary FibrosisStem Cell TransplantationClinical Trials as TopicHumansRetrospective StudiesClinical trialPulmonary fibrosisStem cell

Identifiers

PMID41588478
PMCPMC12836833

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.